Page last updated: 2024-09-03

celastrol and Cancer of Colon

celastrol has been researched along with Cancer of Colon in 7 studies

Research

Studies (7)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's5 (71.43)24.3611
2020's2 (28.57)2.80

Authors

AuthorsStudies
Chen, X; Gao, P; Lin, Q; Liu, D; Wang, J; Wong, YK; Zhang, J; Zhang, X; Zhou, J; Zhu, Y1
Barg, E; Bęben, D; Emhemmed, F; Frąszczak, J; Gębczak, K; Moreira, H; Muller, CD; Nowak, P; Radajewska, A; Siwiela, O; Szyjka, A1
Barg, E; Moreira, H; Paliszkiewicz, K; Szyjka, A1
Kim, JK; Park, JH1
Duan, G; Lu, F; Lv, L; Qi, Y; Wang, R; Yan, H; Zhang, T; Zhao, L; Zhou, F1
Choi, KS; Jeong, SA; Kim, JY; Kim, YS; Kwon, YJ; Lee, AR; Yoon, MJ1
Aggarwal, BB; Chaturvedi, MM; Cho, SG; Kannappan, R; Liu, M; Prasad, S; Sung, B; Yadav, VR1

Other Studies

7 other study(ies) available for celastrol and Cancer of Colon

ArticleYear
Quantitative chemical proteomics reveals anti-cancer targets of Celastrol in HCT116 human colon cancer cells.
    Phytomedicine : international journal of phytotherapy and phytopharmacology, 2022, Volume: 101

    Topics: Colonic Neoplasms; HCT116 Cells; Humans; Pentacyclic Triterpenes; Proteins; Proteomics

2022
Combination of Irinotecan and Melatonin with the Natural Compounds Wogonin and Celastrol for Colon Cancer Treatment.
    International journal of molecular sciences, 2023, May-31, Volume: 24, Issue:11

    Topics: Antineoplastic Agents; Apoptosis; Cell Line, Tumor; Colonic Neoplasms; Humans; Irinotecan; Melatonin

2023
Prooxidative Activity of Celastrol Induces Apoptosis, DNA Damage, and Cell Cycle Arrest in Drug-Resistant Human Colon Cancer Cells.
    Oxidative medicine and cellular longevity, 2019, Volume: 2019

    Topics: Apoptosis; Cell Cycle Checkpoints; Colonic Neoplasms; DNA Damage; Humans; Pentacyclic Triterpenes; Tripterygium; Triterpenes

2019
Pristimerin, a naturally occurring triterpenoid, attenuates tumorigenesis in experimental colitis-associated colon cancer.
    Phytomedicine : international journal of phytotherapy and phytopharmacology, 2018, Mar-15, Volume: 42

    Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Antineoplastic Agents, Phytogenic; Apoptosis; Azoxymethane; Cell Cycle; Cell Proliferation; Colitis; Colonic Neoplasms; Cytokines; Dextran Sulfate; Female; Forkhead Box Protein O3; Mice, Inbred BALB C; NF-kappa B; Pentacyclic Triterpenes; Proto-Oncogene Proteins c-akt; Triterpenes

2018
Celastrol Suppresses Tryptophan Catabolism in Human Colon Cancer Cells as Revealed by Metabolic Profiling and Targeted Metabolite Analysis.
    Biological & pharmaceutical bulletin, 2018, Volume: 41, Issue:8

    Topics: Antineoplastic Agents; Cell Survival; Colonic Neoplasms; HCT116 Cells; Humans; Indoleamine-Pyrrole 2,3,-Dioxygenase; Kynurenine; Metabolomics; Pentacyclic Triterpenes; Triterpenes; Tryptophan

2018
Release of Ca2+ from the endoplasmic reticulum and its subsequent influx into mitochondria trigger celastrol-induced paraptosis in cancer cells.
    Oncotarget, 2014, Aug-30, Volume: 5, Issue:16

    Topics: Apoptosis; Breast Neoplasms; Calcium; Cell Line, Tumor; Colonic Neoplasms; Endoplasmic Reticulum; Female; Humans; MCF-7 Cells; Mitochondria; Pentacyclic Triterpenes; Transfection; Triterpenes

2014
Celastrol suppresses invasion of colon and pancreatic cancer cells through the downregulation of expression of CXCR4 chemokine receptor.
    Journal of molecular medicine (Berlin, Germany), 2010, Volume: 88, Issue:12

    Topics: Breast Neoplasms; Cell Line, Tumor; Chemokine CXCL12; Colonic Neoplasms; Down-Regulation; Drug Screening Assays, Antitumor; Female; Gene Expression Regulation, Neoplastic; HSP90 Heat-Shock Proteins; Humans; Neoplasm Invasiveness; NF-kappa B; Organ Specificity; Pancreatic Neoplasms; Pentacyclic Triterpenes; Protein Processing, Post-Translational; Receptors, CXCR4; Triterpenes; Tumor Necrosis Factor-alpha

2010